Neurology Self-Assessment

An ideal resource for current and comprehensive board prep, Neurology Self-Assessment, 2nd Edition, thoroughly covers the core and subspecialty topics you’ll encounter on your exam. This companion volume to Bradley and Daroff's Neurology in Clinical Practice provides detailed answer explanations and convenient cross-references to Bradley’s. With a focus on assessing subspecialty strengths and weaknesses, it’s the ideal preparation for board certification, maintenance of certification, in-training examinations, and neurology examinations for medical students.

• Features six examinations of 100+ questions each that follow the board exam blueprint, with detailed answer explanations and references to Bradley and Daroff’s Neurology in Clinical Practice, 8th Edition.
• Covers basic neuroscience, behavioral neurology, and psychiatry; clinical neurology topics such as headache, cerebrovascular disease, and neuro-infectious disease; and increasingly tested areas such as ethics and interpersonal skills.
• Provides fully updated questions throughout, with new questions on diagnostics, immunotherapies, gene therapies, new FDA-approved drugs, and new devices.
• Contains numerous illustrations such as anatomy, imaging, histology slides, and clinical photos, just as you might find on the actual board exam.
• Includes excellent coverage of key topics such as neurochemistry and neurophysiology, new immune-mediated therapies, child neurology, metabolic diseases, and much more.
• Offers interactive online tests that allow you to get immediate feedback.
• An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date.

·         Updates to diagnostics (neuroimmunology, dementia, neuro-oncology and neuromuscular)·         New Questions on immunotherapies, gene therapies, new FDA-approved drugs and devices